English
Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bengali
Bosnian
Bulgarian
Catalan
Cebuano
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dutch
Esperanto
Estonian
Filipino
Finnish
French
Frisian
Galician
Georgian
German
Greek
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Korean
Kurdish (Kurmanji)
Kyrgyz
Lao
Latin
Latvian
Lithuanian
Luxembourgish
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Pashto
Persian
Polish
Portuguese
Punjabi
Romanian
Russian
Samoan
Scottish Gaelic
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sundanese
Swahili
Swedish
Tajik
Tamil
Telugu
Thai
Turkish
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
- Knowledge Central
- Leadership
- Newsroom
The next big fear for biotech: a “delisting” letter from the Nasdaq
The latest fear plaguing biotech boardrooms isn’t a failed experiment or a huge financial push,…
Read More
Why are most clinical trials failing because of the impact of AI?
Artificial intelligence (AI) research in healthcare is growing, with potential applications being proven across a…
Read More
Astellas New Menopause Drug Fails to Gain FDA Approval.
Astellas’ effort to launch menopause drug candidate fezolinetant hit a snag at the last minute.…
Read More
John Reed soars to the top of the ladder at J&J
John Reed, M.D., Ph.D., Head of Global R&D at Sanofi, has moved to Johnson &…
Read More
Mineralys Upsizes IPO to raise $192M, Seeks to Race Ahead of AstraZeneca
After a long winter, the first signs of spring have brought a smaller patch of…
Read More
Early cancer detection: The key to saving lives
Most cancers are quickly turning into an “epidemic” and are the second main explanation for…
Read More
Four major mRNA vaccine clinical trials to watch in 2023.
Following the success of messenger RNA (mRNA) vaccines for COVID-19, there has been more investment…
Read More
Can AI really live up to its hype in pharma and life sciences?
By 2025, the pharmaceutical industry is expected to spend more than $3 billion on AI,…
Read More
AI-enabled “Zinc fingers” could help customize treatment for diseases.
n artificial intelligence (AI) program may enable the first simple production of customizable proteins called…
Read More